United Therapeutics reported $79M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Amarin AMRN:US 90.65M 1.72M
Ardelyx ARDX:US $ 19.34M 5.1M
Baxter International BAX:US $ 790M 90M
Bayer BAYN:GR 3.94B 346M
Biocryst Pharmaceuticals BCRX:US $ 34.28M 1.1M
Biogen BIIB:US $ 634.9M 153M
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Emergent Biosolutions EBS:US $ 84.8M 9.4M
Esperion Therapeutics ESPR:US $ 30.38M 5.29M
Gilead Sciences GILD:US $ 1.08B 567M
GlaxoSmithKline GSK:LN 2.68B 227M
Halozyme Therapeutics HALO:US $ 13.83M 60K
Insmed INSM:US $ 56.75M 8.52M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
Intra Cellular Therapies ITCI:US $ 75.46M 4.22M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Lexicon Pharmaceuticals LXRX:US 8.49M 355K
Moderna Inc MRNA:US 268M 67M
Ptc Therapeutics PTCT:US $ 73.27M 13.28M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Sangamo Biosciences SGMO:US $ 14.91M 1.18M
Sarepta Therapeutics SRPT:US $ 71.84M 6.22M
Seattle Genetics SGEN:US $ 174.22M 36.71M
Teva Pharmaceutical TEVA:IT 819M 39M
United Therapeutics UTHR:US $ 79M 47.9M
Vertex Pharmaceuticals VRTX:US $ 215.2M 39.96M